Piramal is among global drugmakers increasingly seeking to reduce their reliance on China for pharmaceutical ingredients and manufacturing, amid rising geopolitical tensions
The post Piramal Pharma cuts exposure to Chinese raw materials to reduce supply risk appeared first on Home Page.
